USE IN RESEARCH OF FRENCH SNDS REAL-WORLD DATA BY PHARMACEUTICAL COMPANIES: EVOLUTION FROM DATA ACCESS OPENING TO PHARMACEUTICAL COMPANIES IN 2017

被引：0
|
作者：
Perier, M. [1 ]
Bourel, G. [1 ]
de Neuville, B. [1 ]
Floch, O. [1 ]
机构：
[1] OpusLine, Paris, France
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMU111
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [21] The impact of research and development and marketing costs on the profitability of pharmaceutical companies of Tehran Stock Exchange using panel data 2001-2013
    Bayazidi, Yahya
    Rad, Enayatollah Homaie
    Mojahedian, Mehdi
    Toroski, Mehdi
    Nabizadeh, Azita
    Farahmand, Parna
    Nasiri, Banafshe Felezi
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2016, 10 (04) : 467 - 476
  • [22] Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population
    Zhu, Zhuoting
    Jiang, Yu
    Wang, Wei
    Scheetz, Jane
    Shang, Xianwen
    Zhang, Lei
    He, Mingguang
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 (07): : 881 - 891
  • [23] What prevents us from reusing medical real-world data in research
    Julia Gehrmann
    Edit Herczog
    Stefan Decker
    Oya Beyan
    Scientific Data, 10
  • [24] Manage Data Better or Die Biotechnology and pharmaceutical companies can survive and grow only by collecting and making use of gigantic amounts of information
    May M.
    Genetic Engineering and Biotechnology News, 2023, 43 (10): : 40 - 42and44
  • [25] What prevents us from reusing medical real-world data in research
    Gehrmann, Julia
    Herczog, Edit
    Decker, Stefan
    Beyan, Oya
    SCIENTIFIC DATA, 2023, 10 (01)
  • [26] REAL-WORLD USE OF TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM LATIN AMERICA
    Schneeberger, E. E.
    Salas, A.
    Medina, L. F.
    Zacariaz, J. B.
    Mantilla, R. D.
    Sarmiento-Monroy, J. C.
    Elizondo, L. J.
    Garro, B.
    Madariaga, H.
    Gorriz, L.
    Giorgi, R. D. N.
    Butte, K.
    Ventura, R.
    Tate, P.
    Ranza, R.
    Coronado, P.
    Forero, E.
    Rodrigues, W.
    Roa, Y.
    Larroude, M.
    Vasquez, R.
    Belini, A.
    Amador, L.
    Solano, G.
    Sanguino, F.
    Aracena, G.
    Ponce de Leon, D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S73 - S74
  • [27] Real-world data are not always big data: the case for primary data collection on medication use in pregnancy in the context of birth defects research
    Ailes, Elizabeth C.
    Werler, Martha M.
    Howley, Meredith M.
    Jenkins, Mary M.
    Reefhuis, Jennita
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2024, 193 (09) : 1211 - 1214
  • [28] Research and development investment of Chinese chemical pharmaceutical companies under the national pooled procurement: a retrospective panel data analysis, 2013-2022
    Lei, Qianrun
    Wu, Qiyou
    Wang, Zhitao
    Sun, Jing
    Liu, Yuanli
    BMJ OPEN, 2024, 14 (11):
  • [29] Innovative Real-World Data Use for Identifying Stroke Survivors and Access to Rehabilitation in Primary Care in Brazil
    Machline-Carrion, M. Julia
    Girotto, Alysson Nathan
    Nieri, Josue
    Pereira, Pedro Marton
    Cuperman-Poll, Thais
    Serafini, Peter
    STROKE, 2025, 56 (04) : 957 - 964
  • [30] ARIMOCLOMOL IN ADULTS WITH NPC IN A REAL-WORLD SETTING DATA FROM AN EXPANDED ACCESS PROGRAM IN THE USA
    Patterson, Marc
    Ficicioglu, Can
    Pena, Loren
    Julich, Kristina
    Al-Hertani, Walla
    Berry-Kravis, Elizabeth
    Ellis, Alexandra
    Foley, Catherine
    Fogh, Bodil Svanholm
    Greene, Tara
    Gallo, Daniel
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 290 - 290
12345